S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Log in
NYSEAMERICAN:MLSS

Milestone Scientific Competitors

$3.68
-0.03 (-0.81 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$3.37
Now: $3.68
$3.85
50-Day Range
$1.47
MA: $1.89
$2.31
52-Week Range
$0.85
Now: $3.68
$4.40
Volume545,388 shs
Average Volume835,781 shs
Market Capitalization$234.39 million
P/E RatioN/A
Dividend YieldN/A
Beta1.54

Competitors

Milestone Scientific (NYSEAMERICAN:MLSS) Vs. SIEN, IVC, LAKE, UEEC, NTRB, and SRGA

Should you be buying MLSS stock or one of its competitors? Companies in the industry of "surgical appliances & supplies" are considered alternatives and competitors to Milestone Scientific, including Sientra (SIEN), Invacare (IVC), Lakeland Industries (LAKE), United Health Products (UEEC), Nutriband (NTRB), and Surgalign (SRGA).

Sientra (NASDAQ:SIEN) and Milestone Scientific (NYSEAMERICAN:MLSS) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends and risk.

Earnings & Valuation

This table compares Sientra and Milestone Scientific's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sientra$83.70 million4.29$-106,820,000.00($2.29)-3.11
Milestone Scientific$8.38 million27.97$-7,520,000.00($0.16)-23.00

Milestone Scientific has lower revenue, but higher earnings than Sientra. Milestone Scientific is trading at a lower price-to-earnings ratio than Sientra, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Sientra has a beta of 1.81, indicating that its stock price is 81% more volatile than the S&P 500. Comparatively, Milestone Scientific has a beta of 1.54, indicating that its stock price is 54% more volatile than the S&P 500.

Insider and Institutional Ownership

71.0% of Sientra shares are owned by institutional investors. Comparatively, 11.6% of Milestone Scientific shares are owned by institutional investors. 2.8% of Sientra shares are owned by insiders. Comparatively, 27.3% of Milestone Scientific shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Sientra and Milestone Scientific's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Sientra-123.88%-174.05%-38.97%
Milestone Scientific-165.06%-104.43%-67.75%

Analyst Recommendations

This is a summary of recent ratings and price targets for Sientra and Milestone Scientific, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Sientra00603.00
Milestone Scientific01102.50

Sientra currently has a consensus price target of $8.20, indicating a potential upside of 15.17%. Milestone Scientific has a consensus price target of $4.00, indicating a potential upside of 8.70%. Given Sientra's stronger consensus rating and higher possible upside, research analysts clearly believe Sientra is more favorable than Milestone Scientific.

Summary

Sientra beats Milestone Scientific on 9 of the 14 factors compared between the two stocks.

Invacare (NYSE:IVC) and Milestone Scientific (NYSEAMERICAN:MLSS) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends and risk.

Earnings & Valuation

This table compares Invacare and Milestone Scientific's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Invacare$927.96 million0.34$-53,330,000.00($1.06)-8.58
Milestone Scientific$8.38 million27.97$-7,520,000.00($0.16)-23.00

Milestone Scientific has lower revenue, but higher earnings than Invacare. Milestone Scientific is trading at a lower price-to-earnings ratio than Invacare, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Invacare has a beta of 0.94, indicating that its stock price is 6% less volatile than the S&P 500. Comparatively, Milestone Scientific has a beta of 1.54, indicating that its stock price is 54% more volatile than the S&P 500.

Insider and Institutional Ownership

96.7% of Invacare shares are owned by institutional investors. Comparatively, 11.6% of Milestone Scientific shares are owned by institutional investors. 3.2% of Invacare shares are owned by insiders. Comparatively, 27.3% of Milestone Scientific shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Invacare and Milestone Scientific's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Invacare-4.87%-8.76%-3.07%
Milestone Scientific-165.06%-104.43%-67.75%

Analyst Recommendations

This is a summary of recent ratings and price targets for Invacare and Milestone Scientific, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Invacare00203.00
Milestone Scientific01102.50

Invacare currently has a consensus price target of $14.00, indicating a potential upside of 53.85%. Milestone Scientific has a consensus price target of $4.00, indicating a potential upside of 8.70%. Given Invacare's stronger consensus rating and higher possible upside, research analysts clearly believe Invacare is more favorable than Milestone Scientific.

Summary

Invacare beats Milestone Scientific on 9 of the 14 factors compared between the two stocks.

Lakeland Industries (NASDAQ:LAKE) and Milestone Scientific (NYSEAMERICAN:MLSS) are both small-cap industrial products companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends and risk.

Earnings & Valuation

This table compares Lakeland Industries and Milestone Scientific's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Lakeland Industries$107.81 million2.17$3.28 million$0.4564.78
Milestone Scientific$8.38 million27.97$-7,520,000.00($0.16)-23.00

Lakeland Industries has higher revenue and earnings than Milestone Scientific. Milestone Scientific is trading at a lower price-to-earnings ratio than Lakeland Industries, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Lakeland Industries has a beta of 0.03, indicating that its stock price is 97% less volatile than the S&P 500. Comparatively, Milestone Scientific has a beta of 1.54, indicating that its stock price is 54% more volatile than the S&P 500.

Insider and Institutional Ownership

70.8% of Lakeland Industries shares are owned by institutional investors. Comparatively, 11.6% of Milestone Scientific shares are owned by institutional investors. 4.9% of Lakeland Industries shares are owned by insiders. Comparatively, 27.3% of Milestone Scientific shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Lakeland Industries and Milestone Scientific's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Lakeland Industries18.93%28.75%24.67%
Milestone Scientific-165.06%-104.43%-67.75%

Analyst Recommendations

This is a summary of recent ratings and price targets for Lakeland Industries and Milestone Scientific, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Lakeland Industries00303.00
Milestone Scientific01102.50

Lakeland Industries currently has a consensus price target of $31.3333, indicating a potential upside of 7.49%. Milestone Scientific has a consensus price target of $4.00, indicating a potential upside of 8.70%. Given Milestone Scientific's higher possible upside, analysts clearly believe Milestone Scientific is more favorable than Lakeland Industries.

Summary

Lakeland Industries beats Milestone Scientific on 10 of the 14 factors compared between the two stocks.

United Health Products (OTCMKTS:UEEC) and Milestone Scientific (NYSEAMERICAN:MLSS) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends and risk.

Profitability

This table compares United Health Products and Milestone Scientific's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
United Health ProductsN/AN/A-8,666.57%
Milestone Scientific-165.06%-104.43%-67.75%

Risk and Volatility

United Health Products has a beta of -0.26, indicating that its stock price is 126% less volatile than the S&P 500. Comparatively, Milestone Scientific has a beta of 1.54, indicating that its stock price is 54% more volatile than the S&P 500.

Insider and Institutional Ownership

0.6% of United Health Products shares are owned by institutional investors. Comparatively, 11.6% of Milestone Scientific shares are owned by institutional investors. 27.3% of Milestone Scientific shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of recent ratings and price targets for United Health Products and Milestone Scientific, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
United Health Products0000N/A
Milestone Scientific01102.50

Milestone Scientific has a consensus price target of $4.00, indicating a potential upside of 8.70%. Given Milestone Scientific's higher possible upside, analysts clearly believe Milestone Scientific is more favorable than United Health Products.

Earnings & Valuation

This table compares United Health Products and Milestone Scientific's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
United Health ProductsN/AN/A$-6,600,000.00N/AN/A
Milestone Scientific$8.38 million27.97$-7,520,000.00($0.16)-23.00

United Health Products has higher earnings, but lower revenue than Milestone Scientific.

Summary

Milestone Scientific beats United Health Products on 7 of the 11 factors compared between the two stocks.

Milestone Scientific (NYSEAMERICAN:MLSS) and Nutriband (OTCMKTS:NTRB) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability and risk.

Profitability

This table compares Milestone Scientific and Nutriband's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Milestone Scientific-165.06%-104.43%-67.75%
Nutriband-263.80%-53.69%-32.84%

Insider and Institutional Ownership

11.6% of Milestone Scientific shares are owned by institutional investors. 27.3% of Milestone Scientific shares are owned by company insiders. Comparatively, 46.1% of Nutriband shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Milestone Scientific and Nutriband, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Milestone Scientific01102.50
Nutriband0000N/A

Milestone Scientific currently has a consensus target price of $4.00, indicating a potential upside of 8.70%. Given Milestone Scientific's higher possible upside, equities analysts plainly believe Milestone Scientific is more favorable than Nutriband.

Valuation and Earnings

This table compares Milestone Scientific and Nutriband's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Milestone Scientific$8.38 million27.97$-7,520,000.00($0.16)-23.00
Nutriband$370,000.00524.24$-2,720,000.00($0.37)-83.78

Nutriband has lower revenue, but higher earnings than Milestone Scientific. Nutriband is trading at a lower price-to-earnings ratio than Milestone Scientific, indicating that it is currently the more affordable of the two stocks.

Summary

Milestone Scientific beats Nutriband on 7 of the 12 factors compared between the two stocks.

Milestone Scientific (NYSEAMERICAN:MLSS) and Surgalign (NASDAQ:SRGA) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability.

Insider & Institutional Ownership

11.6% of Milestone Scientific shares are owned by institutional investors. Comparatively, 53.5% of Surgalign shares are owned by institutional investors. 27.3% of Milestone Scientific shares are owned by company insiders. Comparatively, 3.7% of Surgalign shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Risk and Volatility

Milestone Scientific has a beta of 1.54, suggesting that its stock price is 54% more volatile than the S&P 500. Comparatively, Surgalign has a beta of 2.21, suggesting that its stock price is 121% more volatile than the S&P 500.

Profitability

This table compares Milestone Scientific and Surgalign's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Milestone Scientific-165.06%-104.43%-67.75%
Surgalign-56.07%-101.34%-18.44%

Earnings & Valuation

This table compares Milestone Scientific and Surgalign's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Milestone Scientific$8.38 million27.97$-7,520,000.00($0.16)-23.00
Surgalign$308.38 million0.60$-211,640,000.00($0.16)-14.25

Milestone Scientific has higher earnings, but lower revenue than Surgalign. Milestone Scientific is trading at a lower price-to-earnings ratio than Surgalign, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current recommendations for Milestone Scientific and Surgalign, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Milestone Scientific01102.50
Surgalign00403.00

Milestone Scientific currently has a consensus target price of $4.00, suggesting a potential upside of 8.70%. Surgalign has a consensus target price of $4.3333, suggesting a potential upside of 90.06%. Given Surgalign's stronger consensus rating and higher possible upside, analysts clearly believe Surgalign is more favorable than Milestone Scientific.

Summary

Surgalign beats Milestone Scientific on 10 of the 13 factors compared between the two stocks.


Milestone Scientific Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Sientra logo
SIEN
Sientra
1.4$7.12-0.3%$359.23 million$83.70 million-4.00Upcoming Earnings
Decrease in Short Interest
Invacare logo
IVC
Invacare
1.6$9.10-1.1%$313.20 million$927.96 million-7.40Analyst Upgrade
Lakeland Industries logo
LAKE
Lakeland Industries
1.4$29.15-0.2%$233.78 million$107.81 million8.28Decrease in Short Interest
News Coverage
Gap Up
UEEC
United Health Products
1.0$1.04-1.0%$232.43 millionN/A-17.33Decrease in Short Interest
Nutriband logo
NTRB
Nutriband
0.7$31.00-0.0%$193.97 million$370,000.00-103.33Increase in Short Interest
News Coverage
Surgalign logo
SRGA
Surgalign
1.8$2.28-0.9%$186.23 million$308.38 million-1.27Decrease in Short Interest
News Coverage
Gap Down
Surgalign logo
SRGA
Surgalign
1.4$2.28-0.9%$186.23 million$308.38 million-1.27Decrease in Short Interest
News Coverage
Gap Down
SMTI
Sanara MedTech
0.8$28.75-1.4%$180.95 million$11.77 million-22.29Decrease in Short Interest
Gap Down
Alpha Pro Tech logo
APT
Alpha Pro Tech
2.0$12.45-0.1%$169.05 million$46.67 million8.53Upcoming Earnings
ReWalk Robotics logo
RWLK
ReWalk Robotics
1.4$2.71-4.4%$90.64 million$4.87 million-2.15Gap Down
Conformis logo
CFMS
Conformis
1.3$0.90-2.2%$85.76 million$77.43 million-2.64Earnings Announcement
Analyst Revision
Gap Down
CollPlant Biotechnologies logo
CLGN
CollPlant Biotechnologies
1.1$13.07-6.0%$74.11 million$2.32 million-6.54Gap Up
Myomo logo
MYO
Myomo
1.0$11.29-8.0%$51.73 million$3.84 million-1.24Upcoming Earnings
News Coverage
Gap Up
POAI
Predictive Oncology
1.3$1.22-2.5%$39.32 million$1.41 million-0.19Gap Down
AHPI
Allied Healthcare Products
0.5$4.46-4.9%$17.89 million$31.89 million0.00Decrease in Short Interest
Gap Up
Advanced Biomedical Technologies logo
ABMT
Advanced Biomedical Technologies
0.0$0.24-29.4%$16.71 million$10,000.000.00
BNKL
Bionik Laboratories
0.7$2.74-0.0%$13.73 million$2.15 million-0.56
NAOV
NanoVibronix
0.5$1.02-5.9%$13.66 million$530,000.00-1.70Gap Up
AVTI
Avitar
0.5$0.00-40.0%$0.00N/A0.00Gap Up
PFND
Pathfinder Cell Therapy
0.0$0.01-0.0%$0.00N/A0.00News Coverage
PCGR
PC Group
0.2$0.00-0.0%$0.00N/A0.00
This page was last updated on 3/6/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.